Philippe Y Ayala - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Journal of Chemical Information and Modeling|July 15, 2021

Artificial Intelligence in Chemistry: Current Trends and Future DirectionsZachary J Baum, Xiang Yu, Philippe Y Ayala, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 13, 2009

Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatographyDakshine Shanmugarajah, Daoyuan Ding, Quili Huang, et al.

Molecules (Basel, Switzerland)|March 21, 2015

Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787Aulma R Parker, Pavankumar N Petluru, Vicki L Nienaber, et al.

Oncotargets and Therapy|February 14, 2015

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787Aulma R Parker, Pavankumar N Petluru, Vicki L Nienaber, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Journal of Chemical Information and Modeling|July 15, 2021

Artificial Intelligence in Chemistry: Current Trends and Future DirectionsZachary J Baum, Xiang Yu, Philippe Y Ayala, et al.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 13, 2009

Analysis of BNP7787 thiol-disulfide exchange reactions in phosphate buffer and human plasma using microscale electrochemical high performance liquid chromatographyDakshine Shanmugarajah, Daoyuan Ding, Quili Huang, et al.

Molecules (Basel, Switzerland)|March 21, 2015

Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787Aulma R Parker, Pavankumar N Petluru, Vicki L Nienaber, et al.

Oncotargets and Therapy|February 14, 2015

Novel covalent modification of human anaplastic lymphoma kinase (ALK) and potentiation of crizotinib-mediated inhibition of ALK activity by BNP7787Aulma R Parker, Pavankumar N Petluru, Vicki L Nienaber, et al.

Pageof 1